Clinical Use of Nefazodone in Major Depression: A 6-Year Perspective. Use of Nefazodone in Major Depression

View This PDF

NB: This article is only available as a PDF.

Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.

19 Use of Nefazodone in Major Depression. Alan F. Schatzberg, MD, and Maureen R. Prather, Pharm.D., BCPP From the Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, Calif. (Dr. Schatzberg); and the Neuroscience Medical Affairs Department, Bristol-Myers Squibb Company, Steilacoom, Wash. (Dr. Prather). Correspondence to: Alan F. Schatzberg, MD, Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, 401 Quarry Rd., 3rd Floor, Stanford, CA 94305-5717 (e-mail: afschatz@Stanford.edu). 24 Efficacy of Nefazodone in Chronic Depression. Martin B. Keller, MD Correspondence to: Martin B. Keller, MD, Department of Psychiatric and Human Behavior, Brown University, 345 Blackstone Blvd., Providence, RI 09206 (e-mail: Martin_Keller@brown.edu). 27 Effects of Antidepressants on Sleep: Focus on Nefazodone. A. John Rush, MD; Lyle K. Laird, PharmD, BCPP; Clinton W. Wright, PharmD, BCPP From the Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas (Dr. Rush); and the Neuroscience Medical Affairs Department, Bristol-Myers Squibb Company, Denver, Colo. (Dr. Laird) and San Antonio, Tex. (Dr. Wright). Correspondence to: A. John Rush, MD, Department of Psychiatry, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX 75390-9086 (e-mail: jrush@mednet.swmed.edu).

J Clin Psychiatry 2002;63(suppl 1):18-31